Clinical Trials · NCT01014507

Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Cologne
Enrollment
60
Start date
Jan 2004
Locations
See registry
Primary endpoint
FSH level 6 month after end of treatment
View Gonadorelin compound reference